Tuberculosis in renal transplant patients: the experience of a single center in Medellín-Colombia, 2005-2013 [documento electrónico] / Lina Maria Serna Higuita, ; John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Arbey Aristizabal Álzate, ; Catalina Vélez Echeverri, ; Juan José Vanegas Ruiz, ; Isabel Cristina Ramírez Sánchez, ; John Jairo Zuleta Tobón, ; Gustavo Adolfo Zuluaga Valencia,  . - 2014.
Obra : Brazilian Journal of Nephrology

Idioma : Inglés (eng)

Palabras clave :	Graft rejection  kidney transplantation  mycobacterium tuberculosis
Resumen :	Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant.
Mención de responsabilidad :	Lina Maria Serna Higuita, John Fredy Nieto-Ríos, Salomon Daguer-Gonzalez, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Catalina Velez-Echeverri, Juan Jose Vanegas-Ruiz, Isabel Ramirez-Sanchez, Jhon Jairo Zuleta Tobon, Gustavo Adolfo Zuluaga-Valencia
Referencia :	J Bras Nefrol. 2014 Oct-Dec;36(4):512-8.
DOI (Digital Object Identifier) :	10.5935/0101-2800.20140073
PMID :	25517281
Derechos de uso :	CC BY-NC
En línea :	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&l [...]
Enlace permanente :	https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4546